Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Second Degree Heart Block Type 1 (Wenckebach)

Initial Assessment

  • Assess for signs of hemodynamic compromise including hypotension or evidence of low cardiac output, as recommended by the American College of Cardiology 1
  • Obtain a 12-lead ECG to confirm the diagnosis and evaluate for coexisting conduction abnormalities, as suggested by the American Heart Association, published in Circulation 2
  • Perform an echocardiogram to exclude underlying structural heart disease, according to the guidelines in Circulation 2

Management Algorithm

For Asymptomatic Patients:

  • Patients without structural heart disease can participate in all competitive sports and normal activities, as stated in Circulation 2
  • Activity restrictions should be recommended based on the type of structural heart disease, as advised in Circulation 2
  • More frequent monitoring may be warranted for patients with structural heart disease, as recommended in Circulation 2

For Symptomatic Patients:

  • Atropine 0.5 mg IV can be administered, repeated every 5 minutes as needed up to a total dose of 2 mg, as recommended by the American College of Cardiology 3, 1
  • Atropine is indicated for symptomatic type I second-degree AV block associated with acute inferior myocardial infarction, as stated by the American College of Cardiology 3, 1
  • Temporary transvenous pacing should be initiated for hemodynamically unstable patients or those not responding to atropine, as recommended by the American College of Cardiology 3, 1

Special Considerations

Distinguishing Features from Mobitz Type II

  • It's essential to distinguish 2:1 Wenckebach physiology from true Mobitz Type II block, which can usually be achieved with a stress test, as suggested in Circulation 2

Electrophysiological Study Indications

  • Electrophysiological study may be indicated in athletes with Wenckebach AV block and coexisting bundle-branch block, as recommended in Circulation 2
  • Electrophysiological study may be warranted when there is concern for progression to higher-degree AV block, as advised in Circulation 2

Common Pitfalls and Caveats

  • Doses of atropine <0.5 mg may paradoxically worsen AV block due to central reflex stimulation of the vagus, as warned by the American College of Cardiology 1
  • Atropine is not indicated for asymptomatic patients with sinus bradycardia >40 beats/min, as stated by the American College of Cardiology 1
  • Repeated administration of atropine may produce adverse central nervous system effects, including hallucinations and fever, as cautioned by the American College of Cardiology 1

Second Degree Mobitz Type I (Wenckebach) Heart Block

Characteristics and Diagnosis

  • Second degree Mobitz type I (Wenckebach) heart block is characterized by progressive lengthening of the PR interval before a blocked P wave and generally reflects disease within the atrioventricular (AV) node, with a typically benign prognosis that rarely requires intervention in asymptomatic individuals 4, 5
  • Mobitz type I (Wenckebach) is a form of second-degree AV block where some, but not all, atrial impulses are conducted to the ventricles 4, 5
  • The block typically occurs within the AV node (proximal conduction system) rather than below it 4, 5

Clinical Significance and Prognosis

  • Wenckebach block generally has a benign prognosis compared to Mobitz type II block 4, 5
  • It is commonly observed in well-trained endurance athletes, especially during sleep 6
  • Unlike Mobitz type II, Wenckebach rarely progresses to complete heart block or sudden death 4, 5

Evaluation and Management

  • For patients with Wenckebach block, evaluation should include assessment for symptoms attributable to the block (syncope, presyncope, dizziness) 6
  • Echocardiogram to exclude underlying structural heart disease is recommended 6
  • Exercise stress test to observe the response of the conduction system to increased sympathetic tone is suggested 6
  • Asymptomatic patients with isolated Wenckebach block generally require no specific treatment 4, 5
  • For symptomatic patients with marked first-degree or second-degree Mobitz type I AV block with symptoms clearly attributable to the block, permanent pacing may be reasonable, according to the American College of Cardiology 7
  • In athletes with Wenckebach block who have no symptoms or structural heart disease, participation in all competitive athletics is generally permitted 6

Differentiation from Mobitz Type II

  • Mobitz type II typically occurs below the AV node and is considered abnormal 6
  • Mobitz type II has a worse prognosis and is generally considered an indication for permanent pacemaker implantation 6
  • It's essential to distinguish 2:1 Wenckebach physiology from true Mobitz type II block, which can usually be achieved with a stress test 6

REFERENCES